换一批
换一批Determinants of enhanced vulnerability to coronavirus disease 2019 in UK patients with cancer: a European study.
作者：
David J,Pinato [1]
;
Lorenza,Scotti [2]
;
Alessandra,Gennari [3]
;
Emeline,Colomba-Blameble [4]
;
Saoirse,Dolly [5]
;
Angela,Loizidou [6]
;
John,Chester [7]
;
Uma,Mukherjee [8]
;
Alberto,Zambelli [9]
;
Juan,Aguilar-Company [10]
;
Mark,Bower [11]
;
Myria,Galazi [12]
;
Ramon,Salazar [13]
;
Alexia,Bertuzzi [14]
;
Joan,Brunet [15]
;
Ricard,Mesia [16]
;
Ailsa,Sita-Lumsden [5]
;
Johann,Colomba [4]
;
Fanny,Pommeret [4]
;
Elia,Seguí [17]
;
Federica,Biello [3]
;
Daniele,Generali [18]
;
Salvatore,Grisanti [19]
;
Gianpiero,Rizzo [20]
;
Michela,Libertini [21]
;
Charlotte,Moss [22]
;
Joanne S,Evans [23]
;
Beth,Russell [22]
;
Rachel,Wuerstlein [24]
;
Bruno,Vincenzi [25]
;
Rossella,Bertulli [26]
;
Diego,Ottaviani [12]
;
Raquel,Liñan [15]
;
Andrea,Marrari [14]
;
M C,Carmona-García [15]
;
Christopher C T,Sng [12]
;
Carlo,Tondini [9]
;
Oriol,Mirallas [27]
;
Valeria,Tovazzi [19]
;
Vittoria,Fotia [9]
;
Claudia A,Cruz [17]
;
Nadia,Saoudi-Gonzalez [27]
;
Eudald,Felip [16]
;
Ariadna,R Lloveras [15]
;
Alvin J X,Lee [12]
;
Thomas,Newsom-Davis [11]
;
Rachel,Sharkey [11]
;
Chris,Chung [23]
;
David,García-Illescas [27]
;
Roxana,Reyes [17]
;
Yien N,Sophia Wong [12]
;
Daniela,Ferrante [2]
;
Javier,Marco-Hernández [28]
;
Isabel,Ruiz-Camps [29]
;
Gianluca,Gaidano [30]
;
Andrea,Patriarca [30]
;
Anna,Sureda [31]
;
Clara,Martinez-Vila [32]
;
Ana,Sanchez de Torre [33]
;
Lorenza,Rimassa [34]
;
Lorenzo,Chiudinelli [9]
;
Michela,Franchi [9]
;
Marco,Krengli [35]
;
Armando,Santoro [34]
;
Aleix,Prat [36]
;
Josep,Tabernero [37]
;
Mieke,V Hemelrijck [38]
;
Nikolaos,Diamantis [8]
;
Alessio,Cortellini [39]
;
OnCovid study group
作者单位：
Department of Surgery & Cancer, Imperial College London, Hammersmith Hospital, London, UK; Division of Oncology, Department of Translational Medicine, University of Piemonte Orientale, Novara, Italy. Electronic address: david.pinato@imperial.ac.uk.
[1]
Unit of Cancer Epidemiology, Department of Translational Medicine, CPO-Piemonte, University of Piemonte Orientale, Novara, Italy.
[2]
Division of Oncology, Department of Translational Medicine, University of Piemonte Orientale, Novara, Italy.
[3]
Department of Cancer Medicine, Institut Gustave Roussy, University of Paris Saclay, 114 Rue Edouard Vaillant, 94800, Villejuif, France.
[4]
Medical Oncology, Guy's and St Thomas' NHS Foundation Trust (GSTT), London, UK.
[5]
Department of Infectious Diseases, Internal Medicine, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium.
[6]
Medical Oncology, School of Medicine, Cardiff University, Cardiff, UK; Medical Oncology, Velindre Cancer Centre, Cardiff, UK.
[7]
Medical Oncology, Barts Health NHS Trust, London, UK.
[8]
Oncology Unit, ASST Papa Giovanni XXIII, Bergamo, Italy.
[9]
Medical Oncology, Vall d'Hebron University Hospital and Institute of Oncology (VHIO), Barcelona, Spain; Infectious Diseases, Vall d'Hebron University Hospital, Barcelona, Spain.
[10]
Department of Oncology and National Centre for HIV Malignancy, Chelsea and Westminster Hospital, London, UK.
[11]
Cancer Division, University College London Hospitals, London, UK.
[12]
Department of Medical Oncology, ICO L'Hospitalet, Oncobell Program (IDIBELL), CIBERONC, Hospitalet de Llobregat, Spain.
[13]
Medical Oncology and Hematology Unit, Humanitas Cancer Center, IRCCS Humanitas Research Hospital, Via Manzoni 56, Rozzano, 20089, Milan, Italy.
[14]
Department of Medical Oncology, Catalan Institute of Oncology, University Hospital Josep Trueta, Girona, Spain.
[15]
Department of Medical Oncology, Catalan Institute of Oncology, Badalona, Spain.
[16]
Department of Medical Oncology, Hospital Clinic, Barcelona, Spain.
[17]
Multidisciplinary Breast Pathology and Translational Research Unit, ASST Cremona, Italy; Department of Medical, Surgical and Health Sciences, University of Trieste, Italy.
[18]
Medical Oncology Unit, Spedali Civili, Brescia, Italy.
[19]
Medical Oncology Unit, Fondazione IRCCS Policlinico San Matteo, Pavia, Italy.
[20]
Medical Oncology Unit, Fondazione Poliambulanza Istituto Ospedaliero, Brescia, Italy.
[21]
Translational Oncology and Urology Research (TOUR), School of Cancer and Pharmaceutical Sciences, King's College London, London, UK.
[22]
Department of Surgery & Cancer, Imperial College London, Hammersmith Hospital, London, UK.
[23]
Department of Gynecology and Obstetrics, Breast Center and Gynecological Cancer Center and CCC Munich, University Hospital Munich, Munich, Germany.
[24]
Policlinico Universitario Campus Bio-Medico, Rome, Italy.
[25]
Medical Oncology, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.
[26]
Medical Oncology, Vall d'Hebron University Hospital and Institute of Oncology (VHIO), Barcelona, Spain.
[27]
Department of Internal Medicine, Hospital Clinic, Barcelona, Spain.
[28]
Infectious Diseases, Vall d'Hebron University Hospital, Barcelona, Spain.
[29]
Division of Haematology, Department of Translational Medicine, University of Piemonte Orientale and Maggiore della Carità Hospital, Novara, Italy.
[30]
Haematology Department, ICO Hospitalet, Hospitalet de Llobregat, IDIBELL, Universitat de Barcelona, Barcelona, Spain.
[31]
Fundació Althaia Manresa, Manresa, Spain.
[32]
Hospital Universitario XII de Octubre Madrid, Spain.
[33]
Department of Biomedical Sciences, Humanitas University, Via Rita Levi Montalcini, 20090 Pieve Emanuele, Milan, Italy; Medical Oncology and Hematology Unit, Humanitas Cancer Center, IRCCS Humanitas Research Hospital, Via Manzoni 56, Rozzano, 20089, Milan, Italy.
[34]
Division of Radiotherapy, Department of Translational Medicine, University of Piemonte Orientale and Azienda Ospedaliera Maggiore Della Carita, Novara, Italy.
[35]
Department of Medical Oncology, Catalan Institute of Oncology, Badalona, Spain; Translational Genomics and Targeted Therapies in Solid Tumors, IDIBAPS, Barcelona, Spain.
[36]
Medical Oncology, Vall d'Hebron University Hospital and Institute of Oncology (VHIO), IOB-Quiron, UVic-UCC, Barcelona, Spain.
[37]
Medical Oncology, Guy's and St Thomas' NHS Foundation Trust (GSTT), London, UK; Translational Oncology and Urology Research (TOUR), School of Cancer and Pharmaceutical Sciences, King's College London, London, UK.
[38]
Department of Surgery & Cancer, Imperial College London, Hammersmith Hospital, London, UK; Department of Biotechnology and Applied Clinical Sciences, University of L'Aquila, Via Vetoio, 67100, L'Aquila, Italy. Electronic address: a.cortellini@imperial.ac.uk.
[39]
主题词
老年人(Aged);共病现象(Comorbidity);欧洲(Europe);女(雌)性(Female);人类(Humans);男(雄)性(Male);中年人(Middle Aged);肿瘤(Neoplasms);登记(Registries)
DOI
10.1016/j.ejca.2021.03.035
PMID
33932726
发布时间
2024-02-14
- 浏览2
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文
